The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies

M. S. Van Der Veer*, M. De Weers, B. Van Kessel, J. M. Bakker, S. Wittebol, P. W H I Parren, H. M. Lokhorst, T. Mutis

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Article numbere41
JournalBlood cancer journal
Issue number10
Publication statusPublished - 1 Oct 2011

Cite this